Skip to main content
Toggle navigation
Home
Back
Favorite
0
Like
Facebook
Tweet
Optimal Use of IL12/23 for the Management of IBD
Saturday, March 6, 2021
8:00 AM – 8:20 AM
Speaker(s)
David T. Rubin, MD, FACG
This talk is supported by independent educational grants from AbbVie, Inc and Janssen Scientific Affairs, LLC